Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-01-01 @ 4:33 PM
Study NCT ID:
NCT00772304
Status:
COMPLETED
Last Update Posted:
2010-03-02
First Post:
2008-10-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
Sponsor:
Organization: